Association of Guillain-Barre Syndrome With COVID-19: A Case Report and Literature Review.

acute motor and sensory axonal neuropathy amasn covid-19 guillain-barre syndrome sars-cov-2

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
11 Mar 2021
Historique:
entrez: 15 4 2021
pubmed: 16 4 2021
medline: 16 4 2021
Statut: epublish

Résumé

There is growing evidence of neurological involvement in patients with coronavirus disease 19 (COVID-19), suggesting that Guillain-Barre syndrome (GBS) can also occur with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as a neurological complication. Herein, we describe a unique case of a 45-year-old male who manifested with sudden onset progressive symmetric ascending paralysis leading to quadriplegia one week after developing fever, cough, and dyspnea. On examination, he had areflexia in lower limbs and hyporeflexia in upper limbs. Hypoesthesia to fine touch and vibration distal to calf was noted. His reverse transcriptase-polymerase chain reaction (RT-PCR) was positive for COVID-19, and his cerebrospinal fluid (CSF) analysis revealed albumin-cytologic dissociation. The diagnosis of GBS was made based on clinical presentation and neurophysiological studies due to COVID-19. He was commenced on intravenous immunoglobulin, and improvement in his condition was observed. He was discharged to a rehabilitation center for regular physical therapy.

Identifiants

pubmed: 33854850
doi: 10.7759/cureus.13828
pmc: PMC8035985
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e13828

Informations de copyright

Copyright © 2021, Singh et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Neurol Sci. 2021 Jan 15;420:117263
pubmed: 33321326
Viruses. 2019 Dec 20;12(1):
pubmed: 31861926
Neurol Sci. 2020 Jul;41(7):1657-1658
pubmed: 32468450
Cureus. 2020 Jun 27;12(6):e8871
pubmed: 32754408
J Virol. 2018 Aug 16;92(17):
pubmed: 29925652
N Engl J Med. 2020 Jun 25;382(26):2574-2576
pubmed: 32302082
Front Neurol. 2020 Aug 21;11:909
pubmed: 32973665
J Clin Neurosci. 2020 Jun;76:233-235
pubmed: 32312628
Open Respir Med J. 2020 Dec 31;14:79-86
pubmed: 33717367
Rev Neurol (Paris). 2020 Jun;176(6):518-519
pubmed: 32359804
Neurol Sci. 2020 Nov;41(11):3149-3156
pubmed: 32876777
J Virol. 2008 Aug;82(15):7264-75
pubmed: 18495771

Auteurs

Romil Singh (R)

Critical Care, Mayo Clinic, Rochester, USA.

Saher T Shiza (ST)

Internal Medicine, Deccan College of Medical Sciences, Hyderabad, IND.

Rabeea Saadat (R)

Pediatrics, Holy Family Hospital, Rawalpindi, PAK.

Manal Dawe (M)

Medicine, Capital Medical University, Beijing, CHN.

Usama Rehman (U)

Anaesthesia, Mayo Hospital, Lahore, PAK.

Classifications MeSH